Of the six patients with hypogonadotropic hypogonadism, only Case 13 was treated with sex hormone replacement therapy, because the other five patients (2, 6, 8, 10 and 12) were older and in menopause or refused sex hormone replacement therapy. Here, PLXNA3 is linked to hypogonadotropic hypogonadism.